Scopus Ventures

The three managing partners — Bahram Nour-Omid, Eran Gilad, and Robert Mai — form the investment committee. Nour-Omid brings decades of venture investing and technology exits dating to 1990; Gilad contributes hands-on operating and scaling experience; Mai oversees fund management, partnerships, and compliance, leveraging 25 years in investment banking and a prior role managing a $300 million alternatives portfolio. The firm emphasizes rapid decision-making and keeping its process simple.

Scopus Ventures focuses on direct investments into late-seed and early-stage companies, writing initial checks up to $500,000. The firm's disclosed materials do not reference fund-of-funds commitments; its model is built around direct equity positions in operating companies, supplemented by follow-on capital for existing portfolio holdings.

Based on its disclosed focus areas — enterprise software, business intelligence and automation, cybersecurity, SaaS, digital media, healthcare IT, and fintech — the firm does not publicly target consumer internet, hardware, deep science, or therapeutics. It concentrates on B2B enterprise technologies with scalable, automated solutions.

Scopus sources primarily through its thesis-driven focus on Israeli entrepreneurs. The firm recruits founders in Israel who are ready to enter the US market, leveraging the partners' networks in both countries. It also relies on introductions from its existing portfolio founders, customers, and a network of Fortune 1000 relationships, rather than a broad cold-inbound funnel.